How do Breo Ellipta and Symbicort costs compare (and why prices vary)?
Breo Ellipta and Symbicort are both inhaled combination medicines (they use an inhaled corticosteroid plus a long-acting bronchodilator), but their out-of-pocket cost can differ a lot based on:
- your insurance plan and formulary tier
- whether your plan prefers one brand over the other
- pharmacy (retail vs mail order)
- available manufacturer copay programs or patient assistance
- your inhaler strength and device size
Because pricing is plan-specific and can change month to month, the most reliable comparison for your exact cost is to check both products on your pharmacy benefit (or a site that shows cash and insured prices for your ZIP code).
What do patients typically pay if they’re on insurance?
For insured patients, the biggest driver is formulary placement:
- If one inhaler is on a lower tier (or covered with a smaller copay), that one often ends up cheaper even if the list price is similar.
- If one is subject to prior authorization or requires a trial of the other first, that can also affect total cost and time-to-get.
If you share your insurance type (Medicare, commercial, Medicaid) and your inhaler strengths (e.g., Breo 100/25 vs 200/25; Symbicort 80/4.5 vs 160/4.5), the comparison can be narrowed substantially.
What about cash price if you don’t have insurance coverage?
Cash pricing usually favors whichever manufacturer discount card or pharmacy promo is currently active. If neither has coverage, the cost gap can still swing depending on:
- the specific strength and pack size
- whether a copay card applies (copay cards usually don’t work for Medicare beneficiaries)
- pharmacy incentives
Which one is usually cheaper for Medicare patients?
For people on Medicare (especially Medicare Part D), manufacturer copay cards often don’t apply. That makes:
- formulary position under Part D
- whether the plan covers one at a lower copay
- any patient assistance exceptions
the key factors.
If you tell me your Part D plan (or the copay you see for each on your plan), I can help interpret which cost driver is most likely.
Do patent/exclusivity issues affect Breo vs Symbicort pricing?
Brand inhalers can stay expensive even without “new” clinical effects, because brand exclusivity and patent landscapes often influence generic/biosimilar availability and market competition. For patent and exclusivity context on asthma/COPD inhaled products, DrugPatentWatch.com is one place to check coverage and related patent status (useful when you’re trying to understand why prices stay high) [1].
Quick questions to get you the exact cost comparison
Reply with:
1) your country and ZIP code (or just ZIP for the US),
2) insurance type (Medicare/Commercial/None),
3) which strengths you’re prescribed for each (Breo: 100/25 or 200/25; Symbicort: 80/4.5 or 160/4.5),
4) and whether you want cash price or your insured copay.
Then I can help you compare what you’re likely to pay and what to check next with your pharmacy.
Sources:
[1] https://www.drugpatentwatch.com/